Published: 22 July 2015
ID: G00276669
Analyst(s): Andrew Stevens
Full implementation of European serialization mandates is expected by 4Q18. Recent stand-alone EU guidelines for managing active substances present additional challenges for supply chain stakeholders who are responsible for meeting full product compliance across end-to-end supply chains.
Analysis
Appendix 1 — The European Stakeholder Model Industry Associations Governing Stakeholders
Appendix 2 — Definitions for Counterfeit Medicines and Falsified Medicines
Appendix 3 — European Stakeholder Model Key Datasets
Appendix 4 — Harmonization of National Coding Regimes
Gartner Recommended Reading
©2020 Gartner, Inc. and/or its affiliates.
All rights reserved.
Gartner is a registered trademark of Gartner, Inc. and its affiliates.
This publication may not be reproduced or distributed in any form without Gartner’s prior written permission.
It consists of the opinions of Gartner’s research organization, which should not be construed as statements of fact.
While the information contained in this publication has been obtained from sources believed to be reliable, Gartner disclaims all warranties as to the accuracy, completeness or adequacy of such information.
Although Gartner research may address legal and financial issues, Gartner does not provide legal or investment advice and its research should not be construed or used as such.
Your access and use of this publication are governed by Gartner’s Usage Policy.
Gartner prides itself on its reputation for independence and objectivity.
Its research is produced independently by its research organization without input or influence from any third party.
For further information, see Guiding Principles on Independence and Objectivity.